Age Verification Required

Imperial Peptides

By entering this site you confirm that:

  • ✓You are 18 years of age or older
  • ✓All products are for research purposes only — not for human consumption
  • ✓You are a qualified researcher, scientist, or licensed professional
  • ✓You understand these compounds are not approved by the FDA for human use

This confirmation is stored locally and will not be requested again on this device.

We are currently accepting pre-orders to ensure we have the right products in stock to best serve our customers. If you are interested in a product we do not currently carry, please do not hesitate to reach out — we welcome all product requests.
Home/Research Library/Retatrutide
Back to Research Library
Weight Loss

Retatrutide

Triple GIP/GLP-1/Glucagon Receptor Agonist

A novel triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously.

Overview

Retatrutide is a novel triple agonist that simultaneously targets GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. Research has investigated whether this triple mechanism produces superior metabolic effects compared to dual or single agonists.

Research Information

Early-phase research on retatrutide has demonstrated substantial effects on body weight and metabolic parameters. Studies have explored the additive contributions of glucagon receptor agonism to the already established benefits of GIP/GLP-1 dual agonism. Research has also examined effects on lipid metabolism, liver fat, and cardiovascular risk markers.

Research Dosage Reference

Research protocols use dose-escalation strategies with subcutaneous administration. All dosing information is for research reference only.

Ready to Order?

Purchase high-purity Retatrutide for your research.

Related Research

Cagrilintide

Long-Acting Amylin Analogue

Semaglutide

GLP-1 Receptor Agonist

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist

Disclaimer: All information provided is for educational and research purposes only. This is not medical advice. These compounds are not approved for human use. Always consult with qualified professionals before conducting research.